Workflow
AKL(603722)
icon
Search documents
无锡阿科力科技股份有限公司关于使用闲置自有资金进行委托理财到期赎回的公告
证券代码:603722 证券简称:阿科力 公告编号:2026-003 无锡阿科力科技股份有限公司 关于使用闲置自有资金进行委托理财到期赎回的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 重要内容提示: ●赎回理财产品名称:浙商银行单位结构性存款(EEH25031UT) 截至本公告日,公司已赎回上述投资产品,获得本金及收益合计人民币10,100,555.56元,具体情况如 下: ■ 二、截至本公告日,公司最近十二个月使用自有资金委托理财的情况 单位:万元 ■ ●本次赎回金额:人民币1,000.00万元 无锡阿科力科技股份有限公司第四届董事会第十四次会议、第四届监事会第十四次会议、2024年第二次 临时股东大会审议通过了《关于使用闲置自有资金进行委托理财的议案》,公司对最高额度不超过 20,000万元的闲置自有资金进行委托理财,在确保不影响公司日常运营的情况下在股东大会审议通过之 日起12个月内滚动使用,并授权公司总经理在上述额度内组织实施。具体内容详见公司于2024年10月26 日在《上海证券报》、 ...
阿科力(603722) - 无锡阿科力科技股份有限公司关于使用闲置自有资金进行委托理财到期赎回的公告
2026-02-05 08:00
证券代码:603722 证券简称:阿科力 公告编号:2026-003 无锡阿科力科技股份有限公司 关于使用闲置自有资金进行委托理财到期赎回 的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 公司使用闲置自有资金进行委托理财到期赎回的情况 公司于 2025 年 8 月 8 日购买了浙商银行无锡分行发行的"结构性存款 (EEH25031UT)",具体内容详见公司于 2025 年 8 月 9 日在上海证券交易所网站 (www.sse.com.cn)披露的《无锡阿科力科技股份有限公司关于使用闲置自有资 金委托理财的进展公告》(公告编号:2025-061)。 截至本公告日,公司已赎回上述投资产品,获得本金及收益合计人民币 10,100,555.56 元,具体情况如下: | 受托方 | 产品名 | 收益类 | 金额(万 | 年化收益率 | 产品 | 起止日期 | 现状 | 实际收益 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名 ...
丙烯酸概念上涨2.64% 5股主力资金净流入超千万元
Group 1 - The acrylic acid concept increased by 2.64%, ranking third among concept sectors, with 13 stocks rising, including Hongqiang Co., which hit the daily limit, and Bohai Chemical, Taihe Technology, and Satellite Chemical, which rose by 7.56%, 6.71%, and 6.67% respectively [1] - The acrylic acid sector saw a net inflow of 329 million yuan from main funds, with 10 stocks receiving net inflows, and 5 stocks exceeding 10 million yuan in net inflow, led by Wanhua Chemical with a net inflow of 174 million yuan [2] - The top stocks by net inflow ratio included Hongqiang Co., ST Shenhua, and Daoshengtian, with net inflow ratios of 42.22%, 11.79%, and 5.01% respectively [3] Group 2 - The top performers in the acrylic acid sector included Wanhua Chemical with a 4.39% increase, Tianlong Group with a 6.04% increase, and Hongqiang Co. with a 10.00% increase [3] - The stocks with the largest declines included Guoen Co. with a decrease of 2.04%, Brother Technology with a decrease of 0.87%, and Akoli with a decrease of 0.61% [4] - The trading volume and turnover rates varied, with Hongqiang Co. having a turnover rate of 10.78% and Tianlong Group at 26.90% [3][4]
阿科力发预亏,预计2025年度归母净亏损3150万元至3850万元
Zhi Tong Cai Jing· 2026-01-19 09:45
阿科力(603722)(603722.SH)发布2025年度业绩预告,预计2025年度实现归属于母公司所有者净亏损 3150万元至3850万元。2025年度,公司主要产品聚醚胺受国内新增产能释放影响,产品价格一直处于低 位,公司新产品仍处于客户测试及推广阶段,虽有订单但暂未对公司业绩产生重大影响。 ...
阿科力(603722.SH)发预亏,预计2025年度归母净亏损3150万元至3850万元
智通财经网· 2026-01-19 09:44
Group 1 - The company AkzoNobel (603722.SH) forecasts a net loss attributable to shareholders of the parent company ranging from 31.5 million to 38.5 million yuan for the year 2025 [1] - The main product, polyether amine, is experiencing low prices due to the release of new domestic production capacity [1] - New products are still in the customer testing and promotion phase, resulting in orders that have not yet significantly impacted the company's performance [1]
阿科力(603722) - 2025 Q4 - 年度业绩预告
2026-01-19 08:30
Financial Performance Expectations - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -38.50 million yuan and -31.50 million yuan[3]. - The expected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -47.00 million yuan and -39.00 million yuan[3]. - In the same period last year, the net profit attributable to shareholders of the parent company was -19.65 million yuan, and the net profit after deducting non-recurring gains and losses was -22.17 million yuan[6]. - The earnings per share for the previous year was -0.22 yuan[7]. Reasons for Expected Loss - The primary reason for the expected loss in 2025 is the low product prices of polyether amines due to the release of new domestic production capacity[8]. - New products are still in the customer testing and promotion phase, resulting in orders that have not yet significantly impacted the company's performance[8]. Share-Based Payment and Financial Data - The company will recognize share-based payment expenses related to the restricted stock incentive plan launched in June 2025, affecting profits over the assessment period from 2025 to 2027[8]. - The financial data in the earnings forecast has not been audited by a registered accountant[5]. Investment Risks and Forecast Accuracy - The company emphasizes that there are no significant uncertainties affecting the accuracy of this earnings forecast[9]. - Investors are advised to pay attention to investment risks as the forecast data is preliminary and subject to change in the official 2025 annual report[10].
阿科力:2025年度预亏3150万元至3850万元
Ge Long Hui· 2026-01-19 08:27
格隆汇1月19日丨阿科力(603722.SH)公布,经财务部门初步测算,预计2025年度实现归属于母公司所有 者的净利润为-3,850.00万元到-3,150.00万元。预计2025年度实现归属于母公司所有者的扣除非经常性损 益后的净利润为-4,700.00万元到-3,900.00万元。 本期业绩预亏的主要原因:1、2025年度,公司主要产品聚醚胺受国内新增产能释放影响,产品价格一 直处于低位,公司新产品仍处于客户测试及推广阶段,虽有订单但暂未对公司业绩产生重大影响;2、 公司2025年6月推出的限制性股票激励计划需按会计准则确认股份支付费用,分摊至2025-2027年考核 期,对利润产生影响。 ...
阿科力(603722.SH):2025年度预亏3150万元至3850万元
Ge Long Hui A P P· 2026-01-19 08:16
Core Viewpoint - AkzoNobel (603722.SH) is expected to report a net loss attributable to shareholders of the parent company ranging from -38.50 million to -31.50 million yuan for the fiscal year 2025 [1] Financial Performance - The projected net profit attributable to shareholders, excluding non-recurring gains and losses, is estimated to be between -47.00 million and -39.00 million yuan for 2025 [1] Reasons for Performance Decline - The primary reason for the anticipated loss is the impact of newly released domestic production capacity on the price of the main product, polyether amine, which has remained low [1] - The company's new products are still in the customer testing and promotion phase, resulting in orders that have not yet significantly impacted the company's performance [1] - The restricted stock incentive plan set to launch in June 2025 will require the company to recognize share-based payment expenses according to accounting standards, affecting profits over the assessment period from 2025 to 2027 [1]
阿科力:2025年度预计净亏损3150万至3850万元
Xin Lang Cai Jing· 2026-01-19 08:16
Core Viewpoint - The company Acolyte has announced a projected net loss for 2025, indicating a significant decline compared to the previous year, primarily due to low prices of its main product, polyether amine, and the impact of stock incentive plans [1] Financial Performance - The estimated net profit attributable to the parent company for 2025 is projected to be between -38.50 million and -31.50 million, compared to -19.65 million in the same period last year [1] - The expected non-recurring net profit for 2025 is projected to be between -47.00 million and -39.00 million, compared to -22.17 million in the previous year [1] Product Impact - The main reason for the anticipated loss is the low operating prices of polyether amine, with new products not having a significant impact on overall performance [1] Stock Incentive Plan - The company will need to recognize share-based payment expenses related to its stock incentive plan, contributing to the projected losses [1]
今日124只个股跨越牛熊分界线
Market Overview - The Shanghai Composite Index closed at 4089.45 points, above the annual line, with a slight increase of 0.09% [1] - The total trading volume of A-shares reached 17815.48 billion yuan [1] Stocks Breaking Annual Line - A total of 124 A-shares have surpassed the annual line today, with notable stocks showing significant deviation rates [1] - The stocks with the highest deviation rates include: - Keta Power (300153) with a deviation rate of 11.05% and a daily increase of 12.50% [1] - Tianjian Technology (002977) with a deviation rate of 9.75% and a daily increase of 10.00% [1] - Hongbo Pharmaceutical (301230) with a deviation rate of 9.27% and a daily increase of 10.27% [1] Additional Stocks with Notable Performance - Other stocks with significant performance include: - Hongdu Aviation (600316) with a daily increase of 8.58% and a deviation rate of 8.08% [1] - Jiuliang Co. (300808) with a daily increase of 5.79% and a deviation rate of 5.21% [1] - Zhongcheng Technology (920207) with a daily increase of 22.67% and a deviation rate of 4.84% [1] Summary of Stocks with Smaller Deviation Rates - Stocks that have just crossed the annual line with smaller deviation rates include: - Dongfang Guoxin (东方国信) and Fuchun Environmental (富春环保) with minimal deviation rates [1] - The table lists various stocks along with their daily performance metrics, including turnover rates and latest prices [1]